Ghanshyam Palamaner Subash Shantha
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Warfarin | 2 | 2017 | 32 | 1.170 |
Why?
|
| Anticoagulants | 2 | 2017 | 127 | 1.090 |
Why?
|
| Atrial Fibrillation | 3 | 2018 | 331 | 0.990 |
Why?
|
| Brain Ischemia | 1 | 2017 | 146 | 0.520 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2015 | 30 | 0.500 |
Why?
|
| Hypoglycemic Agents | 2 | 2013 | 188 | 0.490 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2015 | 60 | 0.490 |
Why?
|
| Stroke | 2 | 2017 | 585 | 0.490 |
Why?
|
| Drug Dosage Calculations | 1 | 2013 | 8 | 0.460 |
Why?
|
| Myocardial Infarction | 1 | 2017 | 469 | 0.450 |
Why?
|
| Vitamin D Deficiency | 1 | 2014 | 93 | 0.440 |
Why?
|
| Weight Loss | 2 | 2013 | 454 | 0.430 |
Why?
|
| Triglycerides | 1 | 2013 | 230 | 0.420 |
Why?
|
| Vitamin D | 1 | 2014 | 186 | 0.420 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2014 | 144 | 0.410 |
Why?
|
| Heart Failure | 1 | 2017 | 630 | 0.390 |
Why?
|
| Lipoproteins, HDL | 1 | 2013 | 253 | 0.380 |
Why?
|
| Retrospective Studies | 7 | 2017 | 3514 | 0.340 |
Why?
|
| Risk Factors | 8 | 2018 | 3876 | 0.330 |
Why?
|
| Sex Factors | 4 | 2018 | 674 | 0.320 |
Why?
|
| Neoplasms | 1 | 2015 | 695 | 0.310 |
Why?
|
| Propensity Score | 2 | 2017 | 41 | 0.300 |
Why?
|
| Patient Admission | 2 | 2017 | 62 | 0.290 |
Why?
|
| Administration, Oral | 2 | 2017 | 185 | 0.280 |
Why?
|
| Chi-Square Distribution | 2 | 2017 | 302 | 0.280 |
Why?
|
| Proportional Hazards Models | 3 | 2017 | 759 | 0.280 |
Why?
|
| Multivariate Analysis | 2 | 2017 | 696 | 0.260 |
Why?
|
| Cataract | 2 | 2016 | 10 | 0.250 |
Why?
|
| Aged | 9 | 2018 | 10398 | 0.230 |
Why?
|
| Incidence | 3 | 2017 | 1207 | 0.220 |
Why?
|
| Coronary Artery Disease | 2 | 2017 | 397 | 0.220 |
Why?
|
| Aged, 80 and over | 4 | 2018 | 4050 | 0.210 |
Why?
|
| Treatment Outcome | 4 | 2018 | 3358 | 0.210 |
Why?
|
| Male | 10 | 2018 | 19488 | 0.200 |
Why?
|
| Humans | 14 | 2018 | 32297 | 0.200 |
Why?
|
| Female | 10 | 2018 | 20126 | 0.200 |
Why?
|
| United States | 3 | 2018 | 3983 | 0.180 |
Why?
|
| Databases, Factual | 2 | 2018 | 355 | 0.170 |
Why?
|
| Cause of Death | 2 | 2017 | 244 | 0.170 |
Why?
|
| Rural Population | 2 | 2018 | 274 | 0.160 |
Why?
|
| Cataract Extraction | 2 | 2016 | 12 | 0.160 |
Why?
|
| Glaucoma, Angle-Closure | 1 | 2018 | 4 | 0.160 |
Why?
|
| Glaucoma, Open-Angle | 1 | 2018 | 23 | 0.160 |
Why?
|
| Middle Aged | 8 | 2018 | 11949 | 0.150 |
Why?
|
| Catheter Ablation | 1 | 2018 | 67 | 0.150 |
Why?
|
| Medicare Part D | 1 | 2017 | 9 | 0.150 |
Why?
|
| Comparative Effectiveness Research | 1 | 2017 | 25 | 0.150 |
Why?
|
| Patient Readmission | 1 | 2018 | 115 | 0.150 |
Why?
|
| Hemorrhage | 1 | 2017 | 101 | 0.140 |
Why?
|
| Lens Implantation, Intraocular | 1 | 2016 | 3 | 0.140 |
Why?
|
| Lens, Crystalline | 1 | 2016 | 3 | 0.140 |
Why?
|
| Medicare | 1 | 2017 | 206 | 0.130 |
Why?
|
| Shock, Cardiogenic | 1 | 2015 | 7 | 0.130 |
Why?
|
| Coronary Vessels | 1 | 2016 | 158 | 0.130 |
Why?
|
| Time Factors | 2 | 2018 | 2181 | 0.130 |
Why?
|
| India | 4 | 2018 | 65 | 0.120 |
Why?
|
| Calcium | 1 | 2016 | 310 | 0.120 |
Why?
|
| Risk Assessment | 2 | 2018 | 1447 | 0.120 |
Why?
|
| Chest Pain | 1 | 2016 | 197 | 0.120 |
Why?
|
| Pennsylvania | 1 | 2014 | 84 | 0.120 |
Why?
|
| Vision Disorders | 1 | 2013 | 24 | 0.110 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 926 | 0.110 |
Why?
|
| Confidence Intervals | 1 | 2013 | 150 | 0.110 |
Why?
|
| Adult | 6 | 2018 | 9467 | 0.110 |
Why?
|
| Postoperative Complications | 1 | 2018 | 788 | 0.110 |
Why?
|
| Body Mass Index | 2 | 2013 | 921 | 0.110 |
Why?
|
| Behavior Therapy | 1 | 2013 | 102 | 0.110 |
Why?
|
| Caloric Restriction | 1 | 2013 | 96 | 0.100 |
Why?
|
| Linear Models | 1 | 2013 | 454 | 0.100 |
Why?
|
| Odds Ratio | 1 | 2013 | 480 | 0.100 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 779 | 0.090 |
Why?
|
| Motor Activity | 1 | 2013 | 327 | 0.090 |
Why?
|
| Diabetes Complications | 1 | 2012 | 180 | 0.090 |
Why?
|
| Insulin Resistance | 1 | 2013 | 460 | 0.090 |
Why?
|
| Rhabdomyolysis | 1 | 2009 | 7 | 0.090 |
Why?
|
| Community-Acquired Infections | 1 | 2009 | 32 | 0.090 |
Why?
|
| Cross-Sectional Studies | 1 | 2014 | 1522 | 0.090 |
Why?
|
| Cohort Studies | 4 | 2018 | 1832 | 0.080 |
Why?
|
| Sepsis | 1 | 2009 | 156 | 0.080 |
Why?
|
| Sex Distribution | 2 | 2018 | 201 | 0.070 |
Why?
|
| Age Distribution | 2 | 2018 | 210 | 0.070 |
Why?
|
| Prevalence | 2 | 2018 | 986 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2012 | 1428 | 0.060 |
Why?
|
| Gonioscopy | 1 | 2018 | 4 | 0.040 |
Why?
|
| Tonometry, Ocular | 1 | 2018 | 12 | 0.040 |
Why?
|
| Visual Fields | 1 | 2018 | 28 | 0.040 |
Why?
|
| Intraocular Pressure | 1 | 2018 | 41 | 0.040 |
Why?
|
| Inpatients | 1 | 2018 | 78 | 0.040 |
Why?
|
| Recurrence | 1 | 2018 | 266 | 0.040 |
Why?
|
| Comorbidity | 1 | 2018 | 572 | 0.030 |
Why?
|
| Lenses, Intraocular | 1 | 2016 | 2 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 786 | 0.030 |
Why?
|
| Health Status | 1 | 2018 | 402 | 0.030 |
Why?
|
| Visual Acuity | 1 | 2016 | 73 | 0.030 |
Why?
|
| Radial Artery | 1 | 2015 | 17 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 877 | 0.030 |
Why?
|
| Healthcare Disparities | 1 | 2016 | 166 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2016 | 463 | 0.030 |
Why?
|
| Survival Rate | 1 | 2015 | 894 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2013 | 491 | 0.030 |
Why?
|
| Sulfonylurea Compounds | 1 | 2012 | 8 | 0.030 |
Why?
|
| Age Factors | 1 | 2016 | 1204 | 0.030 |
Why?
|
| Pyrazines | 1 | 2012 | 14 | 0.030 |
Why?
|
| Prognosis | 1 | 2016 | 1523 | 0.030 |
Why?
|
| Triazoles | 1 | 2012 | 15 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2012 | 296 | 0.020 |
Why?
|
| Young Adult | 1 | 2018 | 2626 | 0.020 |
Why?
|
| Adolescent | 1 | 2018 | 3571 | 0.020 |
Why?
|
| Overweight | 1 | 2012 | 270 | 0.020 |
Why?
|
| Gram-Positive Bacteria | 1 | 2009 | 3 | 0.020 |
Why?
|
| Creatine Kinase | 1 | 2009 | 12 | 0.020 |
Why?
|
| Insulin | 1 | 2012 | 368 | 0.020 |
Why?
|
| Obesity | 1 | 2012 | 1164 | 0.010 |
Why?
|